Lyfegen: Funding, Investors & Team (Sep 2026)
Lyfegen is a global, independent provider of drug access, pricing and rebate management services and solutions headquartered in Basel, Switzerland and Boston, USA. Lyfegen helps healthcare payers and pharmaceutical companies to find the right price agreements for medicines and to manage drug rebates more efficiently.
Lyfegen has raised $15.9M across 4 funding rounds on record, the most recent a Series A of $5.7M announced in Dec 2024.
That round is below the $14M median round size for Financial Services companies tracked on FundedIQ over the last two years.
Lyfegen Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Lyfegen Funding Rounds
1 of 4 rounds was announced without a disclosed amount and is excluded from the total.
Lyfegen raised $2.2M in an undisclosed round announced in Sep 2020.
2 years later, a Series A of $8.0M was announced in Sep 2022.
8 months later, an undisclosed round was announced in May 2023 with no disclosed amount.
1.6 years later, a Series A of $5.7M was announced in Dec 2024.
Lyfegen Founders and Leadership Team
Contact details for the Lyfegen team: 2 of 2 have an email address on file.
Start 14-day free trial →Lyfegen Funding Compared to Other Financial Services Startups
Lyfegen's latest round of $5.7M is below the median round in Financial Services. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lyfegen in Financial Services and Basel
Companies Similar to Lyfegen
You started a business to do meaningful work — not to chase receipts, reconcile bank feeds at midnight, or…
DentaCore is an investment management company that specializes in acquisitions and investment services for…
Insurteam offers its technological benefits to every insurance company that caters to the travel and leisure…
Liquid is a finance app that connects all bank accounts in one place. The app tracks income and expenses…
Porters is an AI-native outsourcing platform that helps banks and fintechs automate their operations.
LumRisk is an independent company, founded in 2013, based in Nyon, Switzerland, that provides…
Companies can issue on-chain bonds and commercial paper using the Obligate platform to raise money from a…
Teylor AG has created a quick and convenient small and medium-sized enterprise (SME) loan system in Germany.…
Ariadne creates intelligent financial simulation tools that utilize data for asset liability management, risk…
Piece is an online platform for investing in real estate that generates income.
The powertool to cut international transaction costs, facilitate team spending, and save time on daily…
Lyfegen Funding FAQs
What does Lyfegen do?
Lyfegen is a global, independent provider of drug access, pricing and rebate management services and solutions headquartered in Basel, Switzerland and Boston, USA. Lyfegen helps healthcare payers and pharmaceutical companies to find the right price agreements for medicines and to manage drug rebates more efficiently.
How much funding has Lyfegen raised?
Lyfegen has raised $15.9M across 4 rounds on record. The most recent is a Series A of $5.7M announced in Dec 2024.
When did Lyfegen last raise funding?
Lyfegen's most recent funding round on record is a Series A of $5.7M, announced in Dec 2024.
Who founded Lyfegen?
FundedIQ lists Nico Mros (Founder) at Lyfegen.
Who is the CEO of Lyfegen?
Girisha Fernando is listed as CEO at Lyfegen.
Where is Lyfegen headquartered?
Lyfegen is based in Basel, Basel-Stadt, Switzerland.
How many employees does Lyfegen have?
Lyfegen is in the 51-100 employee band.
How does Lyfegen's funding compare to other Financial Services startups?
Lyfegen's latest round of $5.7M is below the $14M median round size for Financial Services companies on FundedIQ across 5,745 tracked companies over the last two years.
About FundedIQ's Lyfegen Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lyfegen is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.